sciencedaily.com
Potential culprit identified in lingering Crohn's disease symptoms
Some people with Crohn's disease still have symptoms even when inflammation is under control. This study suggests sulfur-producing gut bacteria and their metabolites might explain those lingering symptoms and point to new research directions.
Adults with Crohn's disease who have persistent symptoms despite remission, gastroenterologists and IBD clinicians, microbiome researchers, and anyone interested in diet-based interventions for symptom management.
What To Know
Researchers at the University of Michigan report that sulfur-producing (sulfidogenic) gut microbes and associated sulfur metabolic pathways were enriched in stool and fecal metabolomes of patients with quiescent Crohn's disease who continue to have symptoms.
The study suggests hydrogen sulfide produced by these bacteria could affect gut barrier function and visceral sensitivity, offering a possible explanation for persistent symptoms despite absence of inflammation. The team plans further validation studies and a pilot trial of a low-sulfur diet.
This paper is research-focused — it compares microbiome and metabolome findings between symptomatic and asymptomatic patients in remission (quiescent disease) and links sulfidogenic organisms/metabolites to lingering symptoms.
It does not establish a proven treatment, but highlights a target (sulfur-producing microbes / hydrogen sulfide pathways) for future study. Clinical changes to care are not implied by this report.
Practical takeaways: For people with Crohn's who have ongoing symptoms despite minimal inflammation, this study points to the gut microbiome — not just inflammation — as a possible contributor. Researchers are exploring a low-sulfur diet and additional cohort studies to confirm whether modifying sulfur metabolism or the microbiome could reduce symptoms.
Limitations: The news story summarizes a single research article; results need independent validation and clinical trials before informing treatment decisions.
This is a single research report (microbiome/metabolome study) summarized by Michigan Medicine via ScienceDaily. Findings are preliminary and observational; they suggest a mechanism and possible interventions (e.g., low-sulfur diet) that require further study and clinical trials before practice changes.
